Most Popular

Check out the most popular stories and multimedia features across the site right now

Anna Legassie
Special Report

Extraordinary tactics, perverse incentives: Makers of top-selling drugs hike prices in lockstep, and patients bear the cost

By Casey Ross

Social media and pharma illo
Business

As social media ‘influencers,’ patients are getting a voice. And pharma is ready to pay up

By Kate Sheridan

Stock market dystopia
Adam's Take

Biotech is looking woozy: ferocious selling and a sense of foreboding

By Adam Feuerstein

Ketogenic diet
Business

A startup for diabetes patients rolls out a new model: Insurers only pay if the service works

By Rebecca Robbins

ER doctors bias
First Opinion

Hey, NRA: I treat gunshot victims. Advocating about firearms is ‘my lane’

By Christopher Lee Bennett

Brigham - Dr. Elizabeth Nabel
Hospitals

Covering the cost of high-priced therapies like CAR-T is ‘not sustainable,’ hospital chief says

By Andrew Joseph

Sean Parker speaks in Philly
Business

Sean Parker: Health care’s big breakthroughs aren’t going to come out of Google or Amazon

By Rebecca Robbins

Robert Moir
In the Lab

How an outsider in Alzheimer’s research bucked the prevailing theory — and clawed for validation

By Sharon Begley

Kratom
Exclusive

HHS recommended that the DEA make kratom a Schedule I drug, like LSD or heroin

By Ike Swetlitz

Pricing gun
First Opinion

Price controls would stifle innovation in the pharmaceutical industry

By Robert J. Easton

Pharmalot

AbbVie deal to sell a hepatitis C pill in poor countries meets criticism

By Ed Silverman

Politics

In Michigan, Medicaid can now pay for drugs based on how well they work

By Ike Swetlitz

HHS Health and Human Services
Politics

HHS will bring in fetal tissue experts for ‘listening session’

By Lev Facher

FDA Campus
Politics

FDA official hints at a tough road ahead for ‘right to try’

By Ike Swetlitz

Driver app
Exclusive

‘We ran out of money’: High-profile startup seeking to connect patients with clinical trials shuts down

By Rebecca Robbins

Enterovirus D-68
Health

CDC investigating burst of possible new cases of polio-like paralysis, as mystery persists

By Helen Branswell

Narcan at pharmacy
Health

Some pharmacies fail to offer easy access to naloxone, or to stock it, despite anti-opioid initiatives

By Andrew Joseph

Congo Ebola - information leaflet
Health

Merck takes key step toward approval of experimental Ebola vaccine

By Helen Branswell

Gabacount
Health

New on the streets: Gabapentin, a drug for nerve pain, and a new target of misuse

By Carmen Heredia Rodriguez — Kaiser Health News

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy